Yaren A - Search Results

1

5-fluorouracil increases the number and complexity of premature complexes in the heart: a prospective study using ambulatory ECG monitoring.

Yilmaz U, Oztop I, Ciloglu A, Okan T, Tekin U, Yaren A, Somali I, Alacacioglu A, Kirimli O. Yilmaz U, et al. Among authors: yaren a. Int J Clin Pract. 2007 May;61(5):795-801. doi: 10.1111/j.1742-1241.2007.01323.x. Int J Clin Pract. 2007. PMID: 17493091

2

Evaluation of cardiotoxicity of a combined bolus plus infusional 5-fluorouracil/folinic acid treatment by echocardiography, plasma troponin I level, QT interval and dispersion in patients with gastrointestinal system cancers.

Oztop I, Gencer M, Okan T, Yaren A, Altekin E, Turker S, Yilmaz U. Oztop I, et al. Among authors: yaren a. Jpn J Clin Oncol. 2004 May;34(5):262-8. doi: 10.1093/jjco/hyh047. Jpn J Clin Oncol. 2004. PMID: 15231861 Clinical Trial.

3

Gemcitabine combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced carcinoma of the pancreas.

Oztop I, Yilmaz U, Yavuzsen T, Yaren A, Tarhan O, Sagol O, Coker A, Alakavuklar M. Oztop I, et al. Among authors: yaren a. Chemotherapy. 2004 Jun;50(3):127-32. doi: 10.1159/000077886. Chemotherapy. 2004. PMID: 15282439 Clinical Trial.

4

Rapid tumor lysis syndrome in a patient with metastatic colon cancer as a complication of treatment with 5-fluorouracil/leucoverin and irinotecan.

Oztop I, Demirkan B, Yaren A, Tarhan O, Sengul B, Ulukus C, Akin D, Sen M, Yilmaz U, Alakavuklar M. Oztop I, et al. Among authors: yaren a. Tumori. 2004 Sep-Oct;90(5):514-6. doi: 10.1177/030089160409000515. Tumori. 2004. PMID: 15656341

5

Bax, bcl-2 and c-kit expression in non-small-cell lung cancer and their effects on prognosis.

Yaren A, Oztop I, Kargi A, Ulukus C, Onen A, Sanli A, Binicier O, Yilmaz U, Alakavuklar M. Yaren A, et al. Int J Clin Pract. 2006 Jun;60(6):675-82. doi: 10.1111/j.1368-5031.2006.00742.x. Int J Clin Pract. 2006. PMID: 16805752

6

Irinotecan combined with infusional 5-fluorouracil and high-dose leucovorin for the treatment of advanced gastric carcinoma as the first-line chemotherapy.

Yilmaz U, Oztop I, Alacacioglu A, Yaren A, Tarhan O, Somali I. Yilmaz U, et al. Among authors: yaren a. Chemotherapy. 2006;52(5):264-70. doi: 10.1159/000094769. Epub 2006 Jul 26. Chemotherapy. 2006. PMID: 16873996

7

Angiotensin-converting enzyme gene polymorphism is associated with anemia in non small-cell lung cancer.

Yaren A, Oztop I, Turgut S, Turgut G, Degirmencioglu S, Demirpence M. Yaren A, et al. Exp Biol Med (Maywood). 2008 Jan;233(1):32-7. doi: 10.3181/0705-RM-141. Exp Biol Med (Maywood). 2008. PMID: 18156303

8

Awareness of breast and cervical cancer risk factors and screening behaviours among nurses in rural region of Turkey.

Yaren A, Ozkilinc G, Guler A, Oztop I. Yaren A, et al. Eur J Cancer Care (Engl). 2008 May;17(3):278-84. doi: 10.1111/j.1365-2354.2007.00856.x. Eur J Cancer Care (Engl). 2008. PMID: 18419631

9

The development of metachronous prostate cancer and chronic myeloid leukemia in a patient with metastatic rectal cancer.

Oztop I, Yaren A, Demirpence M, Alacacioglu I, Tuna B, Piskin O, Yilmaz U. Oztop I, et al. Among authors: yaren a. J BUON. 2008 Apr-Jun;13(2):267-70. J BUON. 2008. PMID: 18555476

10

Association between the polymorphism of the angiotensin-converting enzyme gene and tumor size of breast cancer in premenopausal patients.

Yaren A, Turgut S, Kursunluoglu R, Oztop I, Turgut G, Kelten C, Erdem E. Yaren A, et al. Tohoku J Exp Med. 2006 Oct;210(2):109-16. doi: 10.1620/tjem.210.109. Tohoku J Exp Med. 2006. PMID: 17023764 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters